Medios AG engages in providing specialty pharmaceutical drugs. These are medicines for patients with rare or chronic diseases such as cancer, HIV and hepatitis, whose personalized therapy is often tedious and cost-intensive due to their individual requirements. It operates through the following segments: Specialty Pharma Trade, Personalized Preparations, and Shared Services. The Specialty Pharma Trade segment is an expert partner for specialty pharma drugs in Germany and interacts with market participants specialising in the care of patients with chronic and/or serious illnesses. The Personalized Preparations segment covers the wholesale business, GMP-compliant manufacturing, and supplementary services for pharmacies. The Shared Services segment handles tasks specifically relevant to the capital market for the Medios Group holding activities. The company was founded in 1980 and is headquartered in Berlin, Germany.